Exact Mass: 477.0737

Exact Mass Matches: 477.0737

Found 24 metabolites which its exact mass value is equals to given mass value 477.0737, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Benoxaprofen glucuronide

6-({2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoyl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20ClNO9 (477.0827)


   

Suriclone

6-(7-Chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5H-(1,4)dithiino(2,3-c)pyrrol-5-yl-4-methylpiperazine-1-carboxylate

C20H20ClN5O3S2 (477.0696)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   
   

2-Thiophenecarboxamide, 5-chloro-N-[2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)-3-(trifluoromethyl)phenyl]amino]propyl]

2-Thiophenecarboxamide, 5-chloro-N-[2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)-3-(trifluoromethyl)phenyl]amino]propyl]

C19H19ClF3N3O4S (477.0737)


   
   

1-((2-Bromophenyl)sulfonyl)-5-methoxy-3-((4-methylpiperazin-1-yl)methyl)-1H-indole

1-((2-Bromophenyl)sulfonyl)-5-methoxy-3-((4-methylpiperazin-1-yl)methyl)-1H-indole

C21H24BrN3O3S (477.0722)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist

   

GlcA(b1-3)GalNAc4S

GlcA(b1-3)GalNAc4S

C14H23NO15S (477.0788)


   

Dermatan sulfate

Dermatan sulfate

C14H23NO15S (477.0788)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents D006401 - Hematologic Agents > D000925 - Anticoagulants

   

Chondroitin 4-sulfate

Chondroitin 4-sulfate

C14H23NO15S (477.0788)


   

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H23NO15S (477.0788)


   

1-Methoxy-3-indolylmethyl-glucosinolate

1-Methoxy-3-indolylmethyl-glucosinolate

C17H21N2O10S2- (477.0638)


   

[(E)-[2-(4-methoxy-1H-indol-3-yl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylethylidene]amino] sulfate

[(E)-[2-(4-methoxy-1H-indol-3-yl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylethylidene]amino] sulfate

C17H21N2O10S2- (477.0638)


   

Neoglucobrassicin anion

Neoglucobrassicin anion

C17H21N2O10S2- (477.0638)


   

alpha-D-GlcNAc6S-(1->4)-D-GlcA

alpha-D-GlcNAc6S-(1->4)-D-GlcA

C14H23NO15S (477.0788)


A carbohydrate acid derivative that consists of D-glucuronic acid having a 6-O-sulfo-N-acetyl-alpha-D-glucosaminyl residue attached at position 4. An intermediate glycan in the degradation of heparan sulfate.

   

1-S-[2-(4-methoxy-1H-indol-3-yl)-N-(sulfonatooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[2-(4-methoxy-1H-indol-3-yl)-N-(sulfonatooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

C17H21N2O10S2- (477.0638)


   

IdoA(a1-3)GalNAc4S

IdoA(a1-3)GalNAc4S

C14H23NO15S (477.0788)


   

GlcA(b1-3)GalNAc6S

GlcA(b1-3)GalNAc6S

C14H23NO15S (477.0788)


   

IdoA(a1-3)GalNAc6S

IdoA(a1-3)GalNAc6S

C14H23NO15S (477.0788)


   

GalNAc4S(b1-4)GlcA

GalNAc4S(b1-4)GlcA

C14H23NO15S (477.0788)


   

IdoA2S(a1-3)GalNAc

IdoA2S(a1-3)GalNAc

C14H23NO15S (477.0788)


   

GalNAc4S(b1-4)b-GlcA

GalNAc4S(b1-4)b-GlcA

C14H23NO15S (477.0788)


   

(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2R,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H23NO15S (477.0788)


   

neoglucobrassicin(1-)

neoglucobrassicin(1-)

C17H21N2O10S2 (477.0638)


An indolylmethylglucosinolate that is the conjugate base of neoglucobrassicin, obtained by deprotonation of the sulfo group.

   

4-methoxyglucobrassicin(1-)

4-methoxyglucobrassicin(1-)

C17H21N2O10S2 (477.0638)


An indolylmethylglucosinolate that is the conjugate base of 4-methoxyglucobrassicin, obtained by deprotonation of the sulfo group.